infiltrate. He also has oral pemphigus which presented at age 11 years with severe oral ulceration. He responded to corticosteroids and longer term aminosalicylate and azathioprine as maintenance.
Proband 7
Ulcerative Colitis (pancolitis) diagnosed aged 2 years. Histology demonstrated widespread crypt distortion with cryptitis and increased inflammatory cells more pronounced distally. He required prolonged treatment with corticosteroids and azathioprine to achieve remission but remains well on azathioprine. He also has primary hypothyroidism although auto-antibody screen is repeatedly negative.
Proband 8 Colitis (left sided) classified as IBDU diagnosed aged 3 years presenting with a four month history of bloody diarrhoea. Histology showed active colitis with occasional crypt abscesses and no granulomata. He responded to initial treatment with corticosteroids and has been maintained in remission on amino-salicylates.
Mapped to target reads +/-150bp (%)
72 C2orf74   CAPN10   CARD9   CCL11   CCL2   CCL7   CCNY   CCR6   CD19   CD244   CDKAL1   CPEB4   CREM   CXCR1   CXCR2   DAP   DENND1B   DNMT3A   EIF3C   ERAP2   ERRFI1   ESRRA   EXOC3   FADS1   FASLG   FCGR2A   FCGR2B   FIGNL1   FUT2   GALC   GCKR   GMPPB   GNA12   GPR35   GPR65   GPX1   GPX4   GSDMB   HLA-DQA1   HLA-DQA2   HLA-DRA   HLA-DRB1   HLA-DRB5   HORMAD2   HSPA6   ICAM1   ICAM3   ICOSLG   IFNG   IKZF1   IKZF3   IL10   IL10RA   IL10RB   IL12B   IL17REL   IL18R1   IL18RAP   IL19   IL1R2   IL1RL1   IL1RL2   IL2   IL20   IL21   IL23R   IL26   IL27   IL2RA   IL3   IL7R   INPP5E   IRF1   IRF5   IRGM   ITLN1   JAK2   KIF1A   KIF21B   LACC1   LAT   LIF   LRRK2   LSP1   LST1   LTA   LTB   MLX   MMEL1   MST1   MTMR3   MUC1   MUC19   NDFIP1   NKX2-3   NOD2   ORMDL3   PARK7   PIM3   PLCH2   PLCL1   PNMT   PRDM1   PRDX5   PSMG1   PTGER4   PTPN2   PTPN22   PUS10   RASIP1   REL   RNPEPL1   RTEL1   SBNO2   SCAMP3   SDCCAG3   SEC16A   SERINC3   SH2B1   SLC11A1   SLC22A4   SLC22A5   SLC2A4RG   SMAD3   SNAPC4   SP140   STAT3   STMN3   SULT1A1   SULT1A2   TAB1   TAGAP   THADA   TNF   TNFRSF14   TNFRSF6B   TNFRSF9   TNFSF11   TNFSF15   TNFSF18   TNFSF4   TNFSF8   TNPO3   TYK2   UBA7   UBE2D1   UTS2   VAMP3   YDJC   ZBTB46   ZFP36L1   ZFP90   ZGPAT   ZMIZ1   ZNF365   ZPBP 
ZPBP2
Supplementary N/A = not applicable, NR = not reported, NR ‡ indicates variants that despite not being reported in dbSNP132 or 1000 genomes, are reported in dbSNP129 or seen in our in-house control exomes and are therefore not characterised as novel. * Indicates the first bp location of a 3-bp deletion. Where a specific variant is present in a proband, this is indicated by a dot (.) Where a specific variant is present in a proband and has a SIFT score of < 0.05, this is indicated by ◊ †indicates a dinucleotide variant (that for IL18RAP results in a codon change from CTG > AAG, resulting in p.L428K amino acid change). ns=nonsynonymous; sg=stopgain; sp=splicing; fi=frameshift insertion; nd=nonframeshift deletion. C=conservative; MC=moderately conservative; MR=moderately radical; R=radical. B=benign; PoD=possibly damaging; PrD=probably damaging; U=unknown HLA gene variants should be considered with caution due to known challenges of accurate alignment of short read data and consequent difficulty in robust identification of variants from highly divergent HLA haplotypes. Pearson  2 (1 degree freedom) = 0.25, p = 0.62
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